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Medication Education in the Pediatric Rheumatology Clinic
Ashley M. Cooper, MD; Julia G. Harris, MD
Children’s Mercy Kansas City, Kansas City, Missouri

Introduction

Methods

The Children’s Mercy
rheumatology division
previously conducted a
successful initiative to
standardize patient education
about the teratogenic risks of
immunosuppressive
medications. After joining the
Pediatric Rheumatology Care
and Outcomes Improvement
Network (PR-COIN), a multicenter learning network
focused on improving care for
children with juvenile arthritis,
we sought to spread the
successful interventions from
our teratogen project to all
immunomodulators
prescribed in our clinic and to
increase provision to annual
medication education to 85%
by January 2019.

▪ Created medication education documentation template in the
electronic medical record (Figure 1).
▪ Standardized pre-visit planning process.
▪ Spread process to all target medications in March 2017.
▪ Initial medication education done by providers.
▪ Annual medication education done typically by nurses.
▪ Quarterly chart audits with data displayed on run charts.

Results
Our initial chart review in November 2017 demonstrated an average rate of education
documentation among all rheumatology providers of 71%. Subsequent quarterly chart
reviews have demonstrated rates above the baseline (ranging from 73.8 to 84.4%), but not
a consistent trend towards improvement (Figure 2). Considerable variation remains
between the lowest and highest performing providers (Figure 3).
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Conclusion

Figure 1. Screenshot of EMR education documentation template .

We have implemented a standardized process for providing initial and annual education to
patients receiving immunosuppressive medications in the rheumatology clinic by utilizing
pre-visit planning, consistent verbiage and uniform documentation. Despite these
interventions, we have not yet achieved our goal of providing ongoing medication education
to at least 85% of patients prescribed immunosuppressive medications. Next steps include
sharing these results with the rheumatology team and re-assessing clinic processes to
determine factors contributing to variation in medication education rates.

